Journals / MN Kardiyoloji / 2014 / Cilt: 21 - Sayı: 4

A novel echocardiographic parameter for predicting subclinical atherosclerosis in the patients with metabolic syndrome: Aortic propagation velocity

Metabolik sendromlu hastalarda subklinik aterosklerozu öngörmede güncel bir ekokardiyografik parametre: Aortik yayılım hızı

Pages
213–221
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

APV can be used in the evaluation of the presence of subclinical atherosclerosis in the patients with MS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of our study was to investigate the relationship between aortic propagation velocity (APV) and subclinical atherosclerosis, as evaluated by carotid intima-media thickness (CIMT) measurement in the patients with metabolic syndrome (MS).
📊
Key Findings & Data:Material and Method: A total of 122 patients with MS and 80 age- and gendematched controls were included into the study.
💡
Conclusion & Impact:APV can be used in the evaluation of the presence of subclinical atherosclerosis in the patients with MS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of our study was to investigate the relationship between aortic propagation velocity (APV) and subclinical atherosclerosis, as evaluated by carotid intima-media thickness (CIMT) measurement in the patients with metabolic syndrome (MS). Material and Method: A total of 122 patients with MS and 80 age- and gendematched controls were included into the study. APV and CIMT were measured. Patients were divided into two groups according to CIMT measurement: 66 patients with CIMT<0.9 mm were in Group 1 and 56 patients with CIMT &#8805;0.9 mm were in Group 2. Results: The patients with MS had significantly increased CIMT and higher neutrophil to lymphocyte ratio (NLR) and hs-CRP levels than those of controls. APV was significantly lower in the patients with MS than the control group (49.5±13.8 vs 54.4±8.2, p=0.005). Also, APV was significantly lower in Grup 2 than in Grup 1 (40.2±12.0 vs 57.5±9.7, <0.001). CIMT was found to be correlated negati- vely with APV (r=-0.494, p<0.001) and correlated positively with NLR (r=0.334, p<0.001), and hs-CRP (r=0.167, p=0.018). Multivariate logistic regression analysis revealed that APV (p<0.001), NLR (p<0.001), and systolic blood pressure (p=0.034) were independent predictors of subclinical atherosclerosis (CIMT&#8805;0.9 mm). Conclusion: The measurement of APV is an easy and practical method which could be used in daily echocardiographic examination. APV can be used in the evaluation of the presence of subclinical atherosclerosis in the patients with MS.

Özet

Amaç: Çalışmamızın amacı, metabolik sendrom (MS)’lu hastalarda aortik yayılımhızı (AYH) ve karotis intima medya kalınlığı (KİMK) ile değerlendirilen subklinik ateroskleroz arasındaki ilişkiyi araştırmaktı. Gereç ve Yöntem: MS’lu 122 hasta ve yaş ve cinsiyet açısından eşleştirilmiş 80 sağlıklı kontrol çalışmaya dahil edildi. AYH ve KİMK ölçüldü. MS’lu hastalar KİMK ölçümüne göre, KİMK <0,9 mm olan 66 hasta grup 1, KİMK ≥0,9 mm olan 56 hasta ise grup 2 olmak üzere ikiye ayrıldı. Bulgular: MS’lu hastalar önemli ölçüde artmış KİMK ve daha yüksek nötrofil lenfosit (N/L) oranı ve hs-CRP düzeylerine sahipti. AYH kontrole göre MS’lu hastalarda önemli ölçüde daha düşük idi (49,5±13,8 ve 54,4±8,2, p=0,005). Yine, AYH grup 1’e göre grup 2’de önemli ölçüde daha düşük idi (40,2±12,0 ve 57,5±9,7, <0,001). KİMK’nın AYH ile negatif (r=-0,494, p<0,001), N/L oranı (r=0,334, p<0,001) ve hsCRP (r=0,167, p=0,018) ile pozitif korele olduğu bulundu. Çok değişkenli lojistik regresyon analizi AYH (p<0,001), N/L oranı (p<0,001) ve sistolik kan basıncının (p=0,034) subklinik aterosklerozun (KİMK ≥0,9 mm) bağımsız prediktörleri olduğunu gösterdi. Sonuç: AYH ölçümü, günlük ekokardiyografik muayenede kullanılabilen, kolay ve pratik bir yöntemdir. AYH MS’lu hastalarda subklinik aterosklerozun varlığının değerlendirilmesinde kullanılabilir.

🔖

Cite This Article

BAKIRCI, E. M., DEĞİRMENCİ, H., ONK, O. A., DEMİRTAŞ, L., AKBAŞ, E. M., HAMUR, H., BÜYÜKLÜ, M., CEYHUN, G., TOPAL, E. (2014). A novel echocardiographic parameter for predicting subclinical atherosclerosis in the patients with metabolic syndrome: Aortic propagation velocity. MN Kardiyoloji, Cilt: 21 - Sayı: 4, 213–221. https://ajindex.com/articles/297293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Chamberlain AM, Agarwal SK, Ambrose M, Folsom AR, Soliman EZ, Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010;159:850-6
  2. Kabakcı G, Aydın M, Demir I, Kırma C, Özerkan F. Global cardiometabolic risk profile in patients with hyperten- sion: results from the Turkish arm of the pan-European GOOD survey. Turk Kardiyol Dern Arş 2010;38:313-20
  3. Scuteri A, Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the ageassociated increases in vascular thick- ness and stiffness. J Am Coll Cardio 2004;43:1388-95
  4. Bots ML, Grobbee DE. Intima media thickness as a surro- gate marker for generalised atherosclerosis. Cardiovasc Drugs Ther 2002;16:341-51
  5. Gulcan AR, Karakas MS, Akdemir B, Ucar M, Altekin RE, Yılmaz H. Relation between mean platelet volume and subclinical atherosclerosis in patients with metabolic syndrome. Turk Kardiyol Dern Arş 2014;42:22-8
  6. Mallika V, Goswami B, Rajappa M. Atherosclerosis patho- physiology and the role of novel risk factors: a clinicobio- chemical perspective. Angiology 2007;58:513-22
  7. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr. Carotid-wall intima-media thickness and cardiovascular events. N Eng J Med 2011;21:213-221 8. Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. As-sociation of increased carotid intima-media thickness with the extent of coro- nary artery disease. Heart 2004; 90:1286-90
  8. Gunes Y, Tuncer M, Yildirim M, et al. A novel echocardio- graphic method for the prediction of coronary artery dis- ease. Med Sci Moniand cardiovascular events. N Eng J Med 2011;21:213-221 8. Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. As-sociation of increased carotid intima-media thickness with the extent of coro- nary artery disease. Heart 2004; 90:1286-90
  9. Gunes Y, Tuncer M, Yildirim M, et al. A novel echocardio- graphic method for the prediction of coronary artery dis- ease. Med Sci Monit 2008;14:42-6
  10. Simsek H, Sahin M, Gunes Y, et al.A novel echocardio- graphic method as an indicator of endothelial dysfunc- tion in patients with coronary slow flow. Eur Rev Med Pharmacol Sci 2013;17:689-93
  11. Simsek H, Sahin M, Gunes Y, Dogan A, Gumrukcuoglu HA, Tuncer M. A Novel Echocardiographic Method for the Detection of Subclinical Atherosclerosis in Newly Diag- nosed, Untreated Type 2 Diabetes. Ech